AssayIndex
GGPeps cross-section

GGPeps by compound

GGPeps records split by compound, with the index-wide comparison for the same compound beside each one. 33 compounds, 567 records. Cells below n=3 print their raw values instead of a median.

33 compounds567 records
CompoundClassReportsGGPeps median %Index median %Δ (pp)SpecPass %
RetatrutideIncretin9298.1998.41-0.2296.599
BPC-157Tissue-repair7199.0699.15-0.0998.096
SemaglutideIncretin5098.2598.87-0.6297.0100
TirzepatideIncretin3698.4098.44-0.0597.0100
KPVTissue-repair2498.6199.21-0.6099.017
SelankNeuroactive2398.8899.13-0.2599.048
MK-677 (Ibutamoren mesylate)Non-peptide2299.5199.37+0.1498.591
CJC-1295 (no DAC)Growth-hormone2098.2398.61-0.3898.070
LiraglutideIncretin2098.5599.02-0.4797.5100
TB-500Tissue-repair1999.5299.47+0.0598.5100
SemaxNeuroactive1998.6399.17-0.5498.553
Melanotan IIMelanocortin-receptor1699.2399.24-0.0198.569
SermorelinGrowth-hormone1598.8398.94-0.1198.0100
Enclomiphene citrateNon-peptide1499.0999.23-0.1498.564
CagrilintideIncretin1398.1098.59-0.4996.5100
MOTS-cMetabolic1398.7499.18-0.4498.0100
SLU-PP-332Non-peptide1298.6598.69-0.0398.0100
CJC-1295 with DACGrowth-hormone1298.0098.79-0.7997.583
IpamorelinGrowth-hormone1299.4199.48-0.0799.075
ARA-290Tissue-repair1199.0399.45-0.4298.0100
NAD+Non-peptide1098.1998.88-0.6997.0100
IGF-1 LR3Growth-hormone998.1197.75+0.3695.0100
Humanin (HNG)Metabolic7 n=799.2299.47-0.2597.5100
SurvodutideIncretin5 n=597.7498.69-0.9596.5100
N-Acetyl Semax AmideNeuroactive4 n=498.7199.26-0.5598.575
ThymulinTissue-repair4 n=498.7299.06-0.3598.0100
DesmopressinHypothalamic4 n=499.4199.46-0.0598.575
5-Amino-1MQNon-peptide2 n=2n<399.2498.0100
GHRP-6Growth-hormone2 n=2n<399.6599.00
L-Glutathione (reduced)Short2 n=2n<399.0098.550
HexarelinGrowth-hormone2 n=2n<398.7299.050
MGFGrowth-hormone1 n=1n<398.7397.5100
GHRP-2Growth-hormone1 n=1n<399.2299.0100
96.196.897.598.298.999.5100.2RetatrutideRetatrutide: Q1 97.66, median 98.19, Q3 98.85, n=92n=92BPC-157BPC-157: Q1 98.80, median 99.06, Q3 99.53, n=71n=71SemaglutideSemaglutide: Q1 98.00, median 98.25, Q3 98.78, n=50n=50TirzepatideTirzepatide: Q1 97.93, median 98.40, Q3 99.16, n=36n=36KPVKPV: Q1 98.33, median 98.61, Q3 98.77, n=24outlier 97.47outlier 99.93n=24SelankSelank: Q1 98.55, median 98.88, Q3 99.57, n=23n=23MK-677 (Ibutamoren me…MK-677 (Ibutamoren me…: Q1 99.01, median 99.51, Q3 99.90, n=22n=22CJC-1295 (no DAC)CJC-1295 (no DAC): Q1 97.94, median 98.23, Q3 98.57, n=20n=20LiraglutideLiraglutide: Q1 98.28, median 98.55, Q3 98.78, n=20outlier 97.50n=20TB-500TB-500: Q1 99.12, median 99.52, Q3 99.68, n=19n=19SemaxSemax: Q1 98.19, median 98.63, Q3 98.98, n=19n=19Melanotan IIMelanotan II: Q1 98.45, median 99.23, Q3 99.52, n=16n=16SermorelinSermorelin: Q1 98.23, median 98.83, Q3 99.14, n=15n=15Enclomiphene citrateEnclomiphene citrate: Q1 98.32, median 99.09, Q3 99.90, n=14n=14 Purity (% area)
Figure. Distribution per compound where n ≥ 4. Rows are ordered by coverage, not by result.